Leading Pharmaceutical and Biopharmaceutical Company

Our Science

Attacking Cancer Cells That Develop Resistance

Scientists find new ways to disarm rogue cells that have developed resistance to cancer therapies.

Explore the different ways
Our Science

Using ‘Omics to Understand Rise in Breast Cancers Among Young Asians

Asian women are diagnosed with breast cancer at earlier ages.

Learn why
Your Health

Breast Cancer Isn’t Just a Woman’s Disease

The numbers remind us that breast cancer does happen in men.

Learn about male breast cancer
Our People

Pfizer's "Butterflies" Offer Support During Breast Cancer

The Butterfly Club is a support network of Pfizer employees who are living with or have survived breast cancer.

Meet our Butterflies

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search
Your Health

A Look at Hereditary Breast Cancer and Genetic Testing

Tarah, a wife and mother who was diagnosed with metastatic breast cancer (MBC) when she was 32 years old.

Read Her Story
Our Science

Using “Molecular Glues” to Hijack the Body’s Garbage Disposal System

A novel approach to drug discovery called targeted protein degradation seeks to destroy troublesome proteins.

Learn More
Latest news
European Commission Approves VYNDAQEL®, the First...

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has approved VYNDAQEL® (tafamidis), a once-daily 61 mg oral capsule, for the treatment of wild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-...

Read more